KPT-185 significantly inhibits cancer cell proliferation and induces cell-cycle arrest and apoptosis, such as cancer cells from acute myeloid leukemia (46), pancreatic cancer (47) and NSCLC, including EGFR-TKI-resistant cell lines (48). This evidence concerns the gene EGFR and acute myeloid leukemia.